ACOG says no to hormone therapy for heart disease prevention

05/24/2013 | PhysiciansBriefing.com

The American College of Obstetricians and Gynecologists issued a committee opinion advising against the use of menopausal hormone therapy for primary or secondary prevention of coronary heart disease. The group said there is not enough evidence linking long-term estrogen treatment or hormone therapy to improved cardiovascular outcomes. "As with younger women, use of hormone therapy and estrogen therapy should be individualized based on each woman's risk-benefit ratio and clinical presentation," ACOG said in the journal Obstetrics & Gynecology.

View Full Article in:

PhysiciansBriefing.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC
Manager/Senior Manager, Health Economist
Avalere Health
Washington, DC
Director, Health Services Analytics
Avalere Health
Washington, DC
Director/Vice President. Health Actuary
Avalere Health
Washington, DC
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD